Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has his Department made of the effecgt of the closure of Shine in Salford on the ability of Salford residents to access the HIV prevention drug PrEP under the PrEP Impact Trial.

My Rt. hon. Friend the Secretary of State for Health and Social Care announced on 30 January 2019 that the pre-exposure prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is currently underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this shortly. Further details on the timescale for implementation will be confirmed in due course.

The Department has made no assessment of the effect of the closure of Shine in Salford. This is a matter for local commissioners.